BCLI - BrainStorm Cell Therapeutics GAAP EPS of -$0.05 beats by $0.02
2024-05-15 09:45:59 ET
More on BrainStorm Cell Therapeutics
- BrainStorm Cell Therapeutics promotes Bob Dagher to Chief Medical Officer
- BrainStorm gains as FDA OKs Phase 3 trial design for ALS therapy
- Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics
- Historical earnings data for BrainStorm Cell Therapeutics
- Financial information for BrainStorm Cell Therapeutics